Toggle navigation
TWunroll
TWunroll
faq
Contact US
Simon Barnett
sbarnettARK
I've gotten a few questions about how the FDA regulates medical devices, chemical reagents, and diagnostic equipment. Quick Thread First, understand there are two main regulatory pathways for diagnostic
Read more
A Thread ()Let's discuss long-read #sequencing, optical mapping, and the implications of a recent study (linked below). Please view my disclosures at the end. I've intentionally made this thread more
Read more
Let's discuss a key aspect of vertical integration for diagnostics companies involved in #oncology testing:Synthetic Biology (#SynBio) We think maximum operating leverage will accrue to those companies who have bought,
Read more
Several molecular diagnostic companies have added COVID-19 testing to their platforms throughout the year. Why? To supplement a temporarily weak core business? To pull down high-margin cashflow for later use?
Read more
The top community questions for tomorrow’s #mARKetUpdate concern our investment thesis around Invitae ($NVTA). I’m going to begin attaching my references () below, as well as some of my previous
Read more
While I think 'liquid biopsies' will be viewed as one of the most important medical breakthroughs of the 2020's, I've got to admit that 'liquid biopsy' is a poor term.
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree